-
7m 13sPart 1 | Session 6 POPCORN Registry: DCB Treatment for Peripheral Artery Disease
-
3m 49sPart 1 | Session 7 MOTIV Bioresorbable Scaffold in BTK Lesions
-
6m 6sPart 1 | Session 8 Improving Clinical Outcomes in Infrapopliteal Lesions With Cre8™ BTK
-
8m 56sPart 1 | Session 9 LIFE-BTK: Esprit BTK System in Narrowed Infrapopliteal Lesions
-
5m 2sPart 1 | Session 1 AVPAS: Lutonix AV Post-Approval Study
-
5m 18sPart 1 | Session 2 The ELEGANCE Registry: Ranger DCB In Under-Represented Groups
-
4m 51sPart 1 | Session 3 RANGER II SFA: 3 Year Patency and 4 Year Clinical Safety
-
4m 48sPart 1 | Session 4 IN.PACT AV ACCESS: Outcomes to Date
LINC 23 - We are joined by Dr Koen Deloose (AZSint Blasius Hospital, BE) to discuss the findings of the TINTIN trial, a prospective-investigator initiated, non-randomized multicenter trial investigating the Luminor DCB in combination with the iVolution self-expandable stent in patients with peripheral arterial disease (PAD).
100 patients with PAD were enrolled in the trial and were followed up at 1, 6, 12, 24, 36, 48 and 60 months after their initial procedure. Findings show that at 48 months, there was a 61% survival rate.
Interview Questions:
- What was the reasoning behind this trial?
- Tell us more about the Luminor DCB and the iVolution Self-expandable stent. Why did you decide to use these in combination?
- What was the patient population and study design?
- What were the main findings revealed at LINC 23?
- What are your take-home messages?
- What further study is still needed?
Recorded remotely from Dendermonde, 2023.
Editor: Jordan Rance
Video Specialist: Dan Brent
Short, accessible Expert Interviews will be available with select faculty focusing on the results, applicability, and impact on future research.
More from this programme
Part 1
Expert Interviews
Short, accessible Expert Interviews with select faculty focusing on the results, applicability, and impact on future research.
Faculty Biographies
Koen Deloose
Director of Vascular Surgery
Director of vascular surgery at AZ Sint-Blasius Hospital, Dendermonde, BE.
Comments